CN101357183A - 一种含有枳实的治疗糖尿病的药物及其制备方法 - Google Patents
一种含有枳实的治疗糖尿病的药物及其制备方法 Download PDFInfo
- Publication number
- CN101357183A CN101357183A CNA2007100585744A CN200710058574A CN101357183A CN 101357183 A CN101357183 A CN 101357183A CN A2007100585744 A CNA2007100585744 A CN A2007100585744A CN 200710058574 A CN200710058574 A CN 200710058574A CN 101357183 A CN101357183 A CN 101357183A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- fructus
- rhizoma
- described medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 16
- 229940079593 drug Drugs 0.000 title abstract description 12
- 244000183685 Citrus aurantium Species 0.000 title abstract 2
- 235000007716 Citrus aurantium Nutrition 0.000 title abstract 2
- 235000000228 Citrus myrtifolia Nutrition 0.000 title 1
- 235000016646 Citrus taiwanica Nutrition 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 75
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 49
- 239000011347 resin Substances 0.000 claims abstract description 29
- 229920005989 resin Polymers 0.000 claims abstract description 29
- 238000010992 reflux Methods 0.000 claims abstract description 16
- 239000000706 filtrate Substances 0.000 claims abstract description 8
- 241001522129 Pinellia Species 0.000 claims abstract description 7
- 239000003480 eluent Substances 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 3
- 238000010828 elution Methods 0.000 claims description 33
- 239000008517 radix Trichosanthis Substances 0.000 claims description 23
- 239000003463 adsorbent Substances 0.000 claims description 21
- 239000012567 medical material Substances 0.000 claims description 21
- 230000006837 decompression Effects 0.000 claims description 18
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 18
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 17
- 238000004064 recycling Methods 0.000 claims description 17
- 235000008216 herbs Nutrition 0.000 claims description 10
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims description 6
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 241000202726 Bupleurum Species 0.000 abstract 1
- 240000004307 Citrus medica Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 240000001745 Rheum palmatum Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241000218989 Trichosanthes Species 0.000 abstract 1
- 230000002745 absorbent Effects 0.000 abstract 1
- 239000002250 absorbent Substances 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 33
- 239000000243 solution Substances 0.000 description 13
- 239000002775 capsule Substances 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 239000006071 cream Substances 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 238000001291 vacuum drying Methods 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 239000006187 pill Substances 0.000 description 4
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 2
- 229940093265 berberine Drugs 0.000 description 2
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229960001052 streptozocin Drugs 0.000 description 2
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 241000594182 Sarcophaga sigma Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 230000001610 euglycemic effect Effects 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940105623 neo-synephrine Drugs 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- -1 once a day Substances 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (28)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100585744A CN101357183B (zh) | 2007-08-02 | 2007-08-02 | 一种含有枳实的治疗糖尿病的药物及其制备方法 |
CA2687492A CA2687492C (en) | 2007-08-02 | 2008-07-28 | A herbal composition, method for preparing the same and use thereof for treating diabetes mellitus |
DK08783574.0T DK2172207T3 (da) | 2007-08-02 | 2008-07-28 | Farmaceutisk sammensætning til behandling af diabetes og fremgangsmåde til fremstilling heraf |
US12/601,236 US8637092B2 (en) | 2007-08-02 | 2008-07-28 | Pharmaceutical composition for treating diabetes and its process for preparation |
MYPI20094878A MY154567A (en) | 2007-08-02 | 2008-07-28 | A pharmaceutical composition for treating diabetes and its process for preparation |
EP08783574A EP2172207B1 (en) | 2007-08-02 | 2008-07-28 | A pharmaceutical composition for treating diabetes and its process for preparation |
NZ581525A NZ581525A (en) | 2007-08-02 | 2008-07-28 | A pharmaceutical composition for treating diabetes and its process for preparation |
AU2008281227A AU2008281227B2 (en) | 2007-08-02 | 2008-07-28 | A pharmaceutical composition for treating diabetes and its process for preparation |
PCT/CN2008/001383 WO2009015557A1 (fr) | 2007-08-02 | 2008-07-28 | Composition pharmaceutique destinée au traitement du diabète et son procédé de préparation |
KR1020107003490A KR101462984B1 (ko) | 2007-08-02 | 2008-07-28 | 당뇨병 치료용 약학적 조성물 및 이의 제조 방법 |
RU2009144878/15A RU2485968C2 (ru) | 2007-08-02 | 2008-07-28 | Лекарственный препарат для лечения диабета и способ его изготовления |
BRPI0812792A BRPI0812792B8 (pt) | 2007-08-02 | 2008-07-28 | método para preparar uma composição farmacêutica para o tratamento de diabetes mellitus e dita composição farmacêutica |
JP2010518477A JP5508264B2 (ja) | 2007-08-02 | 2008-07-28 | 糖尿病治療のための医薬組成物およびその製造方法 |
ARP080103309A AR070306A1 (es) | 2007-08-02 | 2008-07-30 | Una composicion farmaceutica para tratar diabetes mellitus y el metodo para preparar la misma |
HK10104520.9A HK1138206A1 (en) | 2007-08-02 | 2010-05-10 | A pharmaceutical composition for treating diabetes and its process for preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100585744A CN101357183B (zh) | 2007-08-02 | 2007-08-02 | 一种含有枳实的治疗糖尿病的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101357183A true CN101357183A (zh) | 2009-02-04 |
CN101357183B CN101357183B (zh) | 2011-11-30 |
Family
ID=40329869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100585744A Active CN101357183B (zh) | 2007-08-02 | 2007-08-02 | 一种含有枳实的治疗糖尿病的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101357183B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940363A (zh) * | 2015-06-20 | 2015-09-30 | 浙江大学 | 一种枳提取物的体内外降糖用途 |
CN109528968A (zh) * | 2018-12-25 | 2019-03-29 | 济南经华卉典古中医研究所 | 一种治疗2型糖尿病的中药组合物及其制备方法和应用 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110898170B (zh) * | 2018-09-17 | 2022-04-05 | 江苏九旭药业有限公司 | 一种治疗代谢综合征的中药组合物及其制剂 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1919277B (zh) * | 2005-08-24 | 2011-11-30 | 天津天士力制药股份有限公司 | 一种药物组合物在制备增强胰岛素敏感性药物中的应用 |
-
2007
- 2007-08-02 CN CN2007100585744A patent/CN101357183B/zh active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940363A (zh) * | 2015-06-20 | 2015-09-30 | 浙江大学 | 一种枳提取物的体内外降糖用途 |
CN104940363B (zh) * | 2015-06-20 | 2018-04-17 | 浙江大学 | 一种枳提取物的体内外降糖用途 |
CN109528968A (zh) * | 2018-12-25 | 2019-03-29 | 济南经华卉典古中医研究所 | 一种治疗2型糖尿病的中药组合物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101357183B (zh) | 2011-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102274447B (zh) | 一种用于治疗糖尿病的药物组合物 | |
AU2008281227B2 (en) | A pharmaceutical composition for treating diabetes and its process for preparation | |
CN100571752C (zh) | 治疗鼻炎的中药复方制剂 | |
CN103223111B (zh) | 一种治疗糖尿病肾病的中药组合物及其制备方法 | |
CN103191298B (zh) | 一种治疗母婴血型不合的中药组合物及其制备方法 | |
CN102885975B (zh) | 一种治疗糖尿病的中药组合物 | |
CN101357183B (zh) | 一种含有枳实的治疗糖尿病的药物及其制备方法 | |
CN102335261A (zh) | 一种治疗黄疸的药物组合物及其制备方法 | |
CN104083640B (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN102872334B (zh) | 一种药物组合物在防治糖尿病中的应用 | |
CN104940596A (zh) | 一种治疗糖尿病肾病的中药组合物及其制备方法 | |
CN107213227A (zh) | 一种改善便秘的中药复方及其制品 | |
CN101085121A (zh) | 一种降血糖、降血脂的中药组合物及制法和应用 | |
CN103735899B (zh) | 一种高血压注射护理药物及其制作方法 | |
CN102824548B (zh) | 一种治疗视疲劳的中药组合物及其制备方法 | |
CN104225425A (zh) | 一种提高免疫力、改善睡眠、预防心脑血管疾病的中药制剂及其制备方法 | |
CN101357182B (zh) | 一种含有乌梅的治疗糖尿病的药物及其制备方法 | |
CN101357181B (zh) | 一种含有柴胡的治疗糖尿病的药物及其制备方法 | |
CN102743461A (zh) | 一种和胃安神的中药组合物、制备方法及其应用 | |
CN103393938B (zh) | 一种降血糖的中药组合物 | |
CN104958615A (zh) | 一种预防和治疗ii糖尿病的中药组合物及其制备方法 | |
CN104352748A (zh) | 一种治疗糖尿病肾病的中药组合物及其制备方法 | |
CN103989940A (zh) | 一种治疗糖尿病的中药组合物 | |
CN101357180A (zh) | 一种含有天花粉的治疗糖尿病的药物及其制备方法 | |
CN103585205B (zh) | 一种金腰草提取物在制备治疗糖尿病药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 300410 Tianjin city Beichen District Huaihe road and road intersection Dingjiang tianzhijiao Park forensic Center for Intellectual Property Department Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: Tasly Pharmaceutical Group Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220615 Address after: 101-1032, F1, building 3, No. 103, Beiqing Road, Haidian District, Beijing 100081 Patentee after: Beijing zhongyitang Technology Co.,Ltd. Address before: 300410 Tianjin Beichen District Huaihe road and Ting Jiang West Road intersection heaven proud of the park Legal Center Intellectual Property Department Patentee before: TASLY PHARMACEUTICAL GROUP Co.,Ltd. |